Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicitas Thol

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Hematology. American Society of Hematology. Education Program|December 10, 2021
What to use to treat AML: the role of emerging therapiesFelicitas Thol
Frontiers of Medicine in China|December 3, 2010
Molecular pathogenesis of acute myeloid leukemia: a diverse disease with new perspectivesFelicitas Thol, Arnold Ganser
Blood Advances|November 13, 2019
Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?Felicitas Thol, Uwe Platzbecker
Hemasphere|June 7, 2021
Treatment for Relapsed/Refractory Acute Myeloid LeukemiaFelicitas Thol, Michael Heuser
Current Treatment Options in Oncology|July 1, 2020
Treatment of Relapsed Acute Myeloid LeukemiaFelicitas Thol, Arnold Ganser
Expert Opinion on Biological Therapy|May 29, 2014
Gemtuzumab ozogamicin in acute myeloid leukemia revisitedFelicitas Thol, Richard F Schlenk
Seminars in Cancer Biology|August 6, 2017
Epigenetics in myelodysplastic syndromesMichael Heuser, Haiyang Yun, Felicitas Thol
Deutsches Arzteblatt International|May 25, 2016
Clonal Hematopoiesis of Indeterminate PotentialMichael Heuser, Felicitas Thol, Arnold Ganser
Blood|November 9, 2023
How I treat refractory and relapsed acute myeloid leukemiaFelicitas Thol, Hartmut Döhner, Arnold Ganser
Leukemia & Lymphoma|September 1, 2011
Update on cytogenetic and molecular changes in myelodysplastic syndromesBrigitte Schlegelberger, Gudrun Göhring, Felicitas Thol, et al.
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Hematology. American Society of Hematology. Education Program|December 10, 2021
What to use to treat AML: the role of emerging therapiesFelicitas Thol
Frontiers of Medicine in China|December 3, 2010
Molecular pathogenesis of acute myeloid leukemia: a diverse disease with new perspectivesFelicitas Thol, Arnold Ganser
Blood Advances|November 13, 2019
Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?Felicitas Thol, Uwe Platzbecker
Hemasphere|June 7, 2021
Treatment for Relapsed/Refractory Acute Myeloid LeukemiaFelicitas Thol, Michael Heuser
Current Treatment Options in Oncology|July 1, 2020
Treatment of Relapsed Acute Myeloid LeukemiaFelicitas Thol, Arnold Ganser
Expert Opinion on Biological Therapy|May 29, 2014
Gemtuzumab ozogamicin in acute myeloid leukemia revisitedFelicitas Thol, Richard F Schlenk
Seminars in Cancer Biology|August 6, 2017
Epigenetics in myelodysplastic syndromesMichael Heuser, Haiyang Yun, Felicitas Thol
Deutsches Arzteblatt International|May 25, 2016
Clonal Hematopoiesis of Indeterminate PotentialMichael Heuser, Felicitas Thol, Arnold Ganser
Blood|November 9, 2023
How I treat refractory and relapsed acute myeloid leukemiaFelicitas Thol, Hartmut Döhner, Arnold Ganser
Leukemia & Lymphoma|September 1, 2011
Update on cytogenetic and molecular changes in myelodysplastic syndromesBrigitte Schlegelberger, Gudrun Göhring, Felicitas Thol, et al.
Pageof 13